These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3194 related articles for article (PubMed ID: 25485915)
41. Low-molecular-weight heparin prophylaxis 24 to 36 hours after degenerative spine surgery: risk of hemorrhage and venous thromboembolism. Strom RG; Frempong-Boadu AK Spine (Phila Pa 1976); 2013 Nov; 38(23):E1498-502. PubMed ID: 23873245 [TBL] [Abstract][Full Text] [Related]
42. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients. Rothberg MB; Pekow PS; Lahti M; Lindenauer PK J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716 [TBL] [Abstract][Full Text] [Related]
53. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice. Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751 [TBL] [Abstract][Full Text] [Related]
54. Predicting recurrent venous thromboembolism in cancer: is it possible? Kyrle PA Thromb Res; 2014 May; 133 Suppl 2():S17-22. PubMed ID: 24862139 [TBL] [Abstract][Full Text] [Related]
55. Venous thromboembolism in cystic fibrosis. Takemoto CM Pediatr Pulmonol; 2012 Feb; 47(2):105-12. PubMed ID: 22006666 [TBL] [Abstract][Full Text] [Related]
56. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients. Cohen AT; Nandini B; Wills JO; Ota S Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000 [TBL] [Abstract][Full Text] [Related]
57. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials. Thaler J; Ay C; Pabinger I Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491 [TBL] [Abstract][Full Text] [Related]
58. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study. Kopolovic I; Lee AY; Wu C Ann Hematol; 2015 Feb; 94(2):329-36. PubMed ID: 25190031 [TBL] [Abstract][Full Text] [Related]
59. [Clinical analysis of 20 pregnant women with venous thromboembolic disease]. Sun P; Dong DN Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281 [TBL] [Abstract][Full Text] [Related]
60. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux. Di Nisio M; Porreca E Drug Des Devel Ther; 2013; 7():973-80. PubMed ID: 24068866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]